Filing Overview
Registrant: Anzu Special Acquisition Corp I, a Delaware special purpose acquisition company. The filing is a Form 8-K dated April 21, 2021, reporting an event under Item 8.01. The filing text refers to Envoy Medical only in the request metadata; it does not identify Envoy Medical as the registrant.
Business Context and Reporting Period
The company announced that holders of its publicly issued units may separately trade the underlying Class A common stock and redeemable warrants beginning April 22. Units that are not separated continue to trade on Nasdaq under the symbol ANZUU.
- Units: ANZUU
- Class A common stock: ANZU
- Redeemable warrants: ANZUW
- Each unit consists of one share of Class A common stock and one-third of one redeemable warrant.
- Each whole warrant is exercisable for one share of Class A common stock at $11.50 per share.
Financial Metrics
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics. It is an announcement concerning the separate trading of securities underlying the company’s units.
Material Changes Versus Prior Period
The filing reports a securities-trading milestone rather than a change in operating or financial performance. It does not provide comparable-period financial information or quantify any material change in the company’s financial condition.
Guidance, Outlook, Risks, and Unusual Items
- Holders seeking to separate units must have their brokers contact American Stock Transfer & Trust Company, the transfer agent.
- No fractional warrants will be issued upon separation; only whole warrants will trade.
- The filing includes customary forward-looking-statement language and refers investors to the risk factors in the company’s IPO prospectus filed March 3, 2021.
- The company states that actual results could differ materially from forward-looking statements and undertakes no obligation to update them except as required by law.
- The filing text states “April 21, 2020” and “April 22, 2020” in describing the announcement and commencement of trading, although the report date is April 21, 2021. This appears to be a date inconsistency that should be verified against the filed exhibit.
Investor Verification Items
- Verify the effective date for separate trading of the securities, given the apparent 2020/2021 date inconsistency.
- Confirm the number of units, shares, and warrants outstanding and the terms governing warrant exercise.
- Review the referenced IPO prospectus and risk factors, particularly those relating to the company’s ability to complete a business combination.
- Confirm whether the filing is relevant to Envoy Medical or solely to Anzu Special Acquisition Corp I, the registrant named in the filing.